Research Program, Women's Cancer
Assistant Professor, Department of Radiology

emory002@umn.edu
612-626-3345 — office
612-899-1424 (pager) — lab
Preferred contact method: e-mail, or call secretary Judy Lally, 612-626-3345

Dr. Emory's clinical profile
(University of Minnesota Physicians Web site)

Dr. Emory attended the University of Minnesota Medical School and completed his radiology residency at the Mayo Clinic College of Medicine.

Research Interests

1. Radiofrequency ablation of breast cancer
2. MRS and MRI of breast cancer at very high magnetic field
3. High-risk breast MRI screening: Contralateral cancer detection in young patients with personal history of breast cancer
4. MRI evaluation of skin thickening in patients with advanced breast cancer

Selected Publications

Bolan PJ, Meisamy S, Baker EH, Lin J, Emory T, Nelson M, Everson LI, Yee D, Garwood M. In Vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn. Reson Med., 2003; 50: 1134-1143.

Meisamy S, Bolan PJ, Baker EH, Gulbahce E, Everson LI, Nelson M, Emory T, Yee D, Garwood M. Predicting response to neoadjuvant chemotherapy of locally advanced breast cancer with in vivo 1H MRS: A Pilot Study at 4Tesla. Radiology 2004; 233:424-431

Emory TH. Mammography studies revisited. Minn Med. 2004 Feb;87(2):7.

Sina Meisamy, Patrick J. Bolan, Eva H. Baker, Matthew G. Pollema, Chap T. Le, Frederick Kelcz, Mary C. Lechner, Barbara A. Luikens, Richard A. Carlson, Kathy R. Brandt, Kimberly K. Amrami, Michael T. Nelson, Lenore I. Everson, Tim H. Emory, Todd M. Tuttle, Douglas Yee, and Michael Garwood .Adding in Vivo Quantitative 1H MR Spectroscopy to Improve Diagnostic Accuracy of Breast MR Imaging: Preliminary Results of Observer Performance Study at 4.0 T. Radiology 2005; 236: 465-475

Tuttle T, Habermann E, Abraham A, Emory T, Virnig B. Contralateral prophylactic mastectomy for patients with unilateral breast cancer. Expert Review Anticancer Therapy 7(8) 2007